Earth Science Tech, Inc. Reports Strong Q2 Fiscal 2025 Results

Core Insights - Earth Science Tech, Inc. (ETST) reported significant financial growth in its second fiscal quarter, with a 71% year-over-year increase in total assets and a 22.65% increase since the last fiscal year-end [3][7]. Financial Performance - Total assets rose to $8.66 million, up from $5.04 million in Q2 2024, marking a 71.64% increase year-over-year [7]. - Year-to-date, total assets increased from $7.07 million at the end of March 2025 to $8.66 million [7]. - The company reduced its outstanding common shares by 3.57% to 292.8 million, reflecting a commitment to enhancing shareholder value [7]. - Quarterly net profit increased by 18.48%, reaching $0.94 million [7]. - Quarterly revenue grew by 6.24% to $9.05 million [7]. - Gross profit for the quarter rose by 7.3% to $6.72 million [7]. Business Operations - ETST operates as a strategic holding company focused on acquiring and optimizing high-potential businesses, including compounding pharmaceuticals, telemedicine, and real estate development [3]. - The company’s subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, and others, which contribute to its diversified operations [3][4][5][6][9]. - RxCompoundStore.com is a licensed compounding pharmacy serving multiple states and is pursuing further licensure [4]. - Mister Meds, acquired in October 2024, has advanced compounding capabilities and is expanding its licensure [5]. - Peaks Curative operates a telemedicine platform and has recently entered the veterinary market through an acquisition [6].